|
|
Evan D.
Rosen, M.D., Ph.D |
|
Viewpoint on
Diabetes
Evan D. Rosen, M.D., Ph.D.
Assistant Professor of Medicine, Harvard Medical
School; Medical Director, Diabetes, Veritas Medicine. Joins Diabetes
In Control with a feature every 2 weeks. |
|
 |
|
Kristina
Sandstedt, MS |
|
Kristina
Sandstedt, MS, a Certified Exercise Specialist, presents
Motivation:
The
Key to a Healthier Lifestyle
|
| |
|
Dr. Eric S.
Freedland |
|
Dr.
Freedland continues his series “Why Focusing On Intensive Glucose
Control With Drugs Alone Is Counterproductive” with Part 6
More
Evidence of The Single Disease Process
Eric S. Freedland, MD
|
|
|
|
R. Keith
Campbell |
|
R.
Keith Campbell, RPh, CDE, Professor of Pharmacy Washington
State University shares his thoughts on the most important diabetes
milestones in the last 2 years.
|
| |
|
Shafer Monthly Feature
|
|
Exercise:
A Key Treatment for Type 2 Diabetes
Learn
about Exercise and how to introduce it to your patients for better
results. Full
aritcle
By Sherri
Shafer, R.D., CDE, |
|

|
|
TOOLS FOR YOUR PRACTICE
|
|
Take Time to Care...About Diabetes.
Take Time to Care...About Diabetes.
Find out about the New National effort to educate women about their
risks, just
click here:
|
|
|
Dr. Thomas Burke Ph.D
|
Dr. Burke
brings you a case history from Mary Lu W. an RN, CDE, from
Milwaukee, who has had Type 1 diabetes for 35 years and DPN for
5. Mary Lu shares her experience with the Anodyne Therapy System.
Click
Here |
|
|
|
A New Program |
|
The Pharmacy 15 minute
Diabetes ConSult with A1cNow™
A new program for pharmacies to help their
patients with diabetes and generate income by getting reimbursed for
the pharmacist’s knowledge, not just once, but 4 times a year.
Click
Here
|
|

|
|
SUBSCRIBE |
|
| |
|
This
Weeks Newsletter
May 22, 2002, Issue 105
From the Editors
Desk:
I will be attending the
17th Annual ADA Southern Regional Conference on
Diabetes in Boca Raton, FL this weekend. This year the focus is on
Managing Diabetes, Cardiovascular Disease, Obesity and Related
Disorders. I will have a complete report next week. Read more
about this conference at http://www.diabetes.org/src02/prelimprog.asp
All the
winners from our scholarship contest will be contacted this
week--- stay by your phones…
Dr. Richard
Bernsteins’ story of “The
Three Firsts” in Diabetes Care a 3 part series.
This
week part 2 “First to use a blood glucose
self monitoring and bolus/basal insulin dosing to achieve tight
control” and how the ADA, NEJM and AMA thought it was
not possible.
Dr. Evan
Rosens, feature “
Check
out http://www.fwcade.org/ This is the website we
provided for the Tampa Bay Chapter of AADE. If you want one for
your organization just let us know.
Dr. Eric Freedland continues
his series with More Evidence of The
Single Disease Process.
Thanks to all of you for
visiting our website for our 2 year anniversary, Wednesday was a
record day with over 120,000
visits
Consider making Diabetes in Control Your home
page.

Dave Joffe, Editor-in-Chief ; Steve
Freed, Publisher

1. Aspirin
at Bedtime is More Effective*
Click Here
2.
Diabetes To Overpower Health Care System*
Click
Here
3. Item
Revisited:
Blood Pressure
Does Not Predict Heart Disease Risk in Men With Dyslipidemia
Click
Here
4. Insulin
Prevents Thrombosis Leading To Heart Attack and Stroke
Click
Here
5.
WHO vs. ADA Criteria for Diagnosing Diabetes
Click
Here
6. Split
Bolus Insulin Injection More Effective than Single Bolus Injection
Click
Here
7.
New Treatment Reverses Autoimmune Disease and Cures Type 1
Diabetes*
Click
Here
8.
40% of Children with Type 1 Have Psychiatric Problems
Click
Here
9. Metformin Increases Fertility in PCOS
Patients
Click
Here
10. Statin
Drugs Increase Risk of Peripheral Neuropathy*
Click
Here
11. Centenarians Children Less Likely to Have Heart
Disease and Diabetes
Click
Here
12. Microvascular Disease Predicts Development of Type
2 Diabetes
Click Here
13. Two
Drinks A Day May Help to Prevent Diabetes
Click
Here
14.
Glargine Reduces Risk 34% for Hypoglycemic Events Over NPH
Click
Here
15. Hyperglycemia May Raise Stroke Risk, Results
from Three Studies
Click Here
News Flash - News Flash
Inhaled Insulin Exubera Removed
from Pfizer’s New Drug List for 2002
Pfizer the
world's largest drug maker, on Thursday removed promising diabetes
treatment Exubera from its list of experimental drugs it is certain
to submit for marketing approval this year.
Exubera, being co-developed with Inhale Therapeutic Systems
Inc. and Aventis, has been delayed several times because the
companies need to analyze the effect of the new drug on patients'
ability to breathe, as we reported in last week’s newsletter
“Inhaled Insulin Efficacious in Study, but Lung Function
Drops”. Click
Here.
As the study shows, it was effective in controlling blood
sugars, but it also slightly hurt breathing ability. Exubera, an inhalable dry
powder form of insulin, is designed to be more convenient than
injections of insulin commonly used by diabetics. Pfizer will submit safety
data which includes lung safety data for the drug in their
application for approval with the FDA.
"If you're going to be flooding the lungs with a hormone
every day, you've got to make sure you're being safe," said an
analyst.
SOON
TO OPEN STUDIES for your participation
1.
A
new feedback study for you and your patients- Using a
medical/nutritional assessment survey
2.
Medical Professional
evaluation study—Educational tear-sheets for your
patients
This
Weeks Item
Revisited:
Blood
Pressure Does Not Predict Heart Disease Risk in Men With
Dyslipidemia
Quote of the Week
"If
you can dream it, you can do it."
Walt
Disney
|
DID YOU
KNOW? |
|

Julia Leszko,
United States Women’s Epee Fencing Champion, was diagnosed
with diabetes when she was 7 years old.. Read
more...>
| | |
|
DIABETES NEWS FLASH
|
|
Top Diabetes Stories
Aspirin at
Bedtime is More Effective
Click
Here.
Diabetes To
Overpower Health Care System
Click
Here
New Treatment Reverses Autoimmune Disease and Cures
Type 1 Diabetes
Click
Here
Statin Drugs Increase Risk of Peripheral
Neuropathy
Click
Here |
|
 |
|
Dr Richard K. Bernstein
|
|
This Months
Corner:
For the next 3 issues we will be telling
Dr. Richard Bernsteins’ story of “The
Three Firsts in Diabetes Care“
|
|
|
|
INSIDE
DIABETES |
|
David
Kiff from the Diabetic Investor shares with us a special
feature: Insulin pump market, where it stands today
and what the future holds. Find out why this market is
following the glucose meter market.
David Kliff, Publisher The Diabetic
Investor
|
|

|
|
In
2 Nutrition |
|
Generate Individualized meal plans for your
patients!
See how your patients can receive over
250 personalized recipes that are ideal for individuals with
diabetes, high cholesterol, heart disease and weight management
problems. |
| |
|
New CME/CE:
|
|
Professional
Education
Joslin Diabetes
Center
Presents Live CME
Courses—click here for list of cities--
Click Here |
 |
|
NEW PRODUCT
|
Accu-Chek
Pocket Compass Software Accu-Chek
Pocket Compass Software is the newest way for you to manage your
diabetes - anywhere you go, in the palm of your hand.
More
info click here! |
|
|
|
PRINT
THE NEWSLETTER |
|
Print this weeks Newsletter Here.
Adobe format 17 pages
Download Adobe
format click here. |
 |
|
SPECIAL FEATURE |
Type 2
Diabetes in Children:
Marilyn Porter brings us very important
information if you are educating children. Please read and Learn! “Adults and
Children: Is There a Difference in Learning?”
By Marilyn Porter, RD, CDE |
|
|
|
NEWS FLASH
!!! |
Interest Groups
Battle Over Medicare Drug Plan Ads
A group of labor unions and allied
seniors' organizations filed a complaint with the Federal Trade
Commission (FTC) Friday, asking the agency to investigate a new
round of issue ads that they say mislead voters about proposed
Medicare prescription drug coverage. Read
More...
| |